T1	chemical 10 22	rubrofusarin
T2	disease_or_phenotypic_feature 23 37	dis-aggregated
T3	disease_or_phenotypic_feature 191 194	CAH
T4	missed_chemical 218 232	hydrocortisone
T5	missed_chemical 234 236	HC
T6	chemical 250 262	testosterone
T7	disease_or_phenotypic_feature 288 312	Ductal carcinoma in situ
T8	disease_or_phenotypic_feature 313 318	(DCIS
T9	chemical 313 318	(DCIS
T10	disease_or_phenotypic_feature 393 411	invasive carcinoma
T11	chemical 483 490	protein
T12	chemical 501 504	fat
T13	disease_or_phenotypic_feature 534 541	disease
T14	chemical 800 808	residual
T15	chemical 1001 1008	retinal
T16	disease_or_phenotypic_feature 1001 1029	retinal cavernous hemangioma
T17	chemical 1136 1143	retinal
T18	disease_or_phenotypic_feature 1144 1159	vascular tumors
T19	chemical 1246 1251	group
T20	disease_or_phenotypic_feature 1287 1299	disease-free
T21	chemical 1487 1493	Proton
T23	disease_or_phenotypic_feature 1560 1566	Glioma
T24	chemical 1611 1619	proteins
T25	chemical 1641 1645	drug
T26	chemical 1727 1741	immunogenicity
T27	disease_or_phenotypic_feature 1743 1754	anaphylaxis
T28	chemical 1995 1999	TTP.
T29	disease_or_phenotypic_feature 1995 1999	TTP.
T30	disease_or_phenotypic_feature 2105 2114	air-water
T31	chemical 2105 2114	air-water
T32	disease_or_phenotypic_feature 2221 2227	cancer
T33	disease_or_phenotypic_feature 2250 2268	prostate carcinoma
T34	chemical 2283 2290	glucose
T35	chemical 2364 2373	oxidative
T37	missed_chemical 2395 2398	ROS
T38	disease_or_phenotypic_feature 2421 2424	SOD
T39	chemical 2538 2547	biomarker
T40	disease_or_phenotypic_feature 2551 2562	sensitivity
T41	chemical 2566 2576	everolimus
T42	disease_or_phenotypic_feature 2595 2610	Ultra-Sensitive
T43	disease_or_phenotypic_feature 2657 2670	Breast Cancer
T44	chemical 2758 2771	Nanoparticles
T45	chemical 2807 2817	metabolite
T46	disease_or_phenotypic_feature 2854 2861	disease
T47	disease_or_phenotypic_feature 2866 2884	multiple sclerosis
T48	disease_or_phenotypic_feature 2907 2912	tumor
T49	chemical 2929 2939	paclitaxel
T50	disease_or_phenotypic_feature 3065 3068	pig
T51	chemical 3194 3198	food
T52	chemical 3401 3405	lead
T53	disease_or_phenotypic_feature 3416 3433	nursing-sensitive
T54	chemical 3469 3476	Glucose
T55	disease_or_phenotypic_feature 3529 3537	diseases
T56	disease_or_phenotypic_feature 3547 3555	diabetes
T57	disease_or_phenotypic_feature 3560 3566	cancer
R1	treats Arg1:T5 Arg2:T3
R4	treats Arg1:T4 Arg2:T3
R5	treats Arg1:T49 Arg2:T48
R3	treats Arg1:T21 Arg2:T23	
T22	missed_disease_or_phenotypic_feature 1715 1725	irritation
T58	missed_disease_or_phenotypic_feature 1767 1772	death
T59	missed_disease_or_phenotypic_feature 1727 1741	immunogenicity
T60	missed_disease_or_phenotypic_feature 1685 1700	adverse effects
T61	corrected_chemical 1601 1645	denatured proteins within a therapeutic drug
R6	causes_or_contributes_to Arg1:T61 Arg2:T60	
R7	causes_or_contributes_to Arg1:T61 Arg2:T22	
R8	causes_or_contributes_to Arg1:T61 Arg2:T58	
R9	causes_or_contributes_to Arg1:T61 Arg2:T27	
R10	causes_or_contributes_to Arg1:T61 Arg2:T59	
T36	corrected_chemical 2729 2771	Long-Persistent Luminescence Nanoparticles
R2	treats Arg1:T36 Arg2:T43	
T62	missed_chemical 2944 2955	ramucirumab
R11	treats Arg1:T62 Arg2:T48	
